CCND1 and neoplasm: As predicted, Table 2 and Figure 2B show that estrogen receptor-alpha (ESR1) and cyclin D1/2 levels (CCND1/2) both effectively predict tamoxifen-sensitivity, as reflected by a reduction in tumor recurrence.